Patients or patience?
I think mxc are at the crossroads. A few things go right and line up (varm Cosmo, strong cannepil sales, Malta development, full gmp, other deals in the wings) and this share is significantly de-risked completely re-rated to 25c+....
conversely if VC falls over the company has approx 12million in bank with a high cash burn and currently minimal income (we’ll know more Monday). They have 6 million euro commitment to Malta which is currently about 9.6 million aud. Cleary if there isn’t significant revenue within 3-6 months (maybe sooner) a CR is on the cards. That will result in more dilution, less trust of managements capabilities and a share price languishing sub 6 cents imo.
I hope the best scenario unfolds for all shareholders and it’s obviously in the directors best interests for income to flow sooner rather than later. I’m sure they are aware of that!
Here’s hoping to REAL revenue in the bank ASAP
- Forums
- ASX - By Stock
- The future for Derma?
Patients or patience? I think mxc are at the crossroads. A few...
-
-
- There are more pages in this discussion • 24 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add RGT (ASX) to my watchlist
|
|||||
Last
30.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.58M |
Open | High | Low | Value | Volume |
30.0¢ | 31.0¢ | 30.0¢ | $2.567K | 8.41K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 47481 | 30.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
31.0¢ | 8026 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 47481 | 0.300 |
1 | 17426 | 0.275 |
1 | 15000 | 0.250 |
1 | 40820 | 0.245 |
1 | 18524 | 0.240 |
Price($) | Vol. | No. |
---|---|---|
0.310 | 8026 | 2 |
0.315 | 2876 | 1 |
0.320 | 2479 | 3 |
0.325 | 5304 | 1 |
0.330 | 2316 | 1 |
Last trade - 15.53pm 21/06/2024 (20 minute delay) ? |
Featured News
RGT (ASX) Chart |
The Watchlist
FHE
FRONTIER ENERGY LIMITED
Adam Kiley, CEO
Adam Kiley
CEO
SPONSORED BY The Market Online